Home > Financial Ratios > FREDUN PHARMACEUTICALS

FREDUN PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
FREDUN PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for FREDUN PHARMACEUTICALS
Please provide your vote to see the results

FREDUN PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025
   Core EBITDA Growth(%) 72.22-

What is the latest Core EBITDA Growth ratio of FREDUN PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of FREDUN PHARMACEUTICALS is 72.22 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar202672.22
Mar2025-

How is Core EBITDA Growth of FREDUN PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2026 72.22
0
Mar2025 0 -

Other Financial Ratios of FREDUN PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of FREDUN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS ₹2,516.6 Cr 5.8% 8.1% 162.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,803.0 Cr 0.2% -5.2% 4.1% Stock Analytics
DIVIS LABORATORIES ₹253,833.0 Cr 4.9% -0.5% 43.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,461.0 Cr -1.1% -8.5% 28.3% Stock Analytics
DR REDDYS LABORATORIES ₹111,463.0 Cr 7.8% 11% 1.2% Stock Analytics
CIPLA ₹109,870.0 Cr 2.3% -2.7% -18.9% Stock Analytics


FREDUN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS

5.8%

8.1%

162.7%

SENSEX

-0.6%

-0.5%

-13.2%


You may also like the below Video Courses